Overview
- 268 inspections across 227 sites are on record.
- 345 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-20.
At a glance
Inspections
268
Sites
227
Observations
345
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Staska Pharmaceuticals, Inc. | 20 Feb 2026 | Human Drugs | On file |
| Zhejiang Chemsyn Pharm Co., Ltd. | 1 May 2025 | Animal Drugs & Feeds | |
| Joyang Laboratories | 25 Apr 2025 | Human Drugs | On file |
| Yancheng Suhai Pharmaceutical Co., Ltd. 0086 515 8328 7829 | 17 Apr 2025 | Human Drugs | |
| Chanel Parfums Beaute | 21 Sep 2023 | Human Drugs |
Sites inspected
Staska Pharmaceuticals, Inc.Bennet, United States1 insp.
Zhejiang Chemsyn Pharm Co., Ltd.Zhou, China1 insp.
Joyang LaboratoriesYancheng, China1 insp.
Yancheng Suhai Pharmaceutical Co., Ltd. 0086 515 8328 7829Yancheng, China1 insp.
Chanel Parfums BeauteChamant, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Torrey M Ward7 shared
Wayne D Mcgrath5 shared
Russell K Riley5 shared
Rita K Kabaso3 shared
Brett R Havranek3 shared
Dariusz Galezowski3 shared
Conner N Mann2 shared
Gretchen L Trendel2 shared
Veronica Fuentes2 shared
Donna K Speer2 shared
Full investigator report
Get the verbatim findings behind Carl A Huffman's 345 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site